Attention Deficit Hyperactivity Disorder in Children and Adults

Size: px
Start display at page:

Download "Attention Deficit Hyperactivity Disorder in Children and Adults"

Transcription

1 Attention Deficit Hyperactivity Disorder in Children and Adults Steven R. Pliszka, MD Professor and Chair Department of Psychiatry The University of Texas Health Science Center at San Antonio

2 Speaker Disclosure Dr. Pliszka has disclosed that he has received research support from Ironshore and he is a consultant for Ironshore.

3 Learning Objective By the end of this activity, the participant should be better able to: 1. Implement the criteria required for a diagnosis of ADHD. 2. Develop a protocol for managing ADHD patients in the office, including medication refills. 3. Identify how comorbid diagnoses such as anxiety, depression, conduct disorder, and learning disabilities can mimic and/or confuse the diagnosis of ADHD. 4. Formulate diagnoses and develop treatment recommendations for patients presenting with ADHD.

4 Making the Diagnosis Unfounded fears An occult medical diagnosis might masquerade as ADHD Missing an underlying psychiatric disorder Depression Mania Psychosis Contributing to the overuse of medication Forgetting that common diseases occur commonly

5 Making the Diagnosis Should never take more than an hour, can be done in 3 minutes with proper preparation (not including note writing) You have the advantage of knowing the family and child (in many cases) When brought up in follow up visit, give rating scales for home and school and schedule 3 minute follow up When parent call in with complaint of ADHD, give script to office staff- send rating scales to home, when returned, schedule parent

6 Interviewing the Parent Review the rating scales from home and school. Look at report card, behavior chart if scales not available. I see there are a lot of symptoms of inattention and/or impulsivity When did they start? (DSM-5 allows onset by age 12) Nearly every day? Impairment school and home? Re-direct extensive Storytelling

7 Interviewing the Parent Academics Grades may not be impaired in early grades Learning disability vs. ADHD Psychological evaluation is NOT required for a diagnosis of ADHD Inconsistent with Learning disability He can do it (school work) when he wants to Able to do work when one on one LD does not masquerade as ADHD (particularly impulsivity) Only when ADHD is treated can true cognitive ability be assessed

8 Ruling out MAJOR Comorbidities Minor depression/anxiety are common in ADHD and are NOT a contradiction to stimulant treatment Many ADHD children discouraged about their lives, this gets better with treatment Questions to ask about depression/anxiety How often does it occur, (daily, weekly rarely)? How long does it last? What does he/she talk about? Self-esteem issues?

9 Comorbidity Major Depressive Disorder Sad/Irritable/Depression 3-5 times per week for at least an hour Chronic low self esteem Suicidal ideation/plan outside of anger outbursts Neurovegetative signs Demoralization/Emotional Lability Intermittent sadness or anger Tied to frustration Brief threats of self-harm that resolve when calm No neurovegetative signs except difficulty falling asleep

10 Interview with Child In young children, focus on depression and anxiety rather than the ADHD Ask concrete questions, quantify Sad/happy, like self/don t like self, hurt self, wish dead/suicide Rules: how parent s punish, fair/unfair, corporal punishment, abuse Psychosis screen

11 Anger Issues Anger/aggression in ADHD most often improve when ADHD is treated Aggression a rare side effect and is often related to rebound Anger/aggression not a contraindication to ADHD treatment unless: Severe, prolong rage attacks Psychotic symptoms co-occurring with anger Self injurious behavior (beyond dropping or head banging, i.e. cutting, suicidal ideation)

12 Methylphenidate (MPH)

13 Methylphenidate (MPH) Apatensio XR- 4% released immediately, 6% as extended release

14 Amphetamine

15 ADHD Medication Guide

16 Side Effects with Methylphenidate and Amphetamine Therapy Many side effects are characteristic of ADHD and improve with stimulant treatment * * Baseline Dextroamphetamine Methylphenidate Mean Severity * * * * * * * * * * 1. * * * *. Trouble Sleeping Poor Appetite Irritable Anxious Daydreams Biting Fingernails Sadness Tics Headaches Nightmares *P<.1 vs placebo, P<.1 vs methylphenidate. Efron D, et al. Pediatrics. 1997;1:

17 Stages of Medication RX for ADHD 1. Trial of a single stimulant, try different formulations for duration action 2. Trial of stimulant in alternate class MPH fail AMP AMP fail MPH 3. Trial of atomoxetine or alpha agonist XR 4. Combination of stimulant and alpha agonist

18 How fast to titrate? Titrations can be done by phone

19 Alpha Agonist Summary Clonidine Increasingly used in single dose in PM for insomnia secondary to stimulants (.5 to.1 mg q HS) Declining role for treatment of daytime ADHD due to efficacy issues as well as sedation Guanfacine Both immediate release and XR used more ADHD itself Non responders to stimulants and atomoxetine Patients with stimulant-induced tics whose ADHD responds only to stimulants

20 Dosing of Alpha Agonists Week Dosage (mg) of Alpha Agonist (Weight < 45 kg) Dosage (mg) of Alpha Agonist (Weight > 45 kg) All weights Baseline Clonidine Guanfacine Clonidine Guanfacine Guanfacine q.h.s..5 q.h.s..1 q.h.s. 1. q.h.s. 1-2 mg b.i.d..5 b.i.d..1 b.i.d. 1. b.i.d. 3 mg t.i.d..5 t.i.d..1 t.i.d. 1. t.i.d. 4 mg

21 Guanfacine XR and Stimulants No difference in somnolence rates between AM and PM administration Wilens et al. Presented at AACAP meeting, New York, 21

22 Clonidine XR and Stimulants Mean age 1.5 years ADHD >26 after 4 weeks of stimulant Kollins et al. Pediatrics 127:e146, 211

23 Rebound When medication wears off, possible that behaviors not only return to baseline, but are worse. Evening behavior- is it just the same or worse? Is it associated with irritability/outbursts not present before meds (or much worse after meds)? If school behavior much improved, but evening behavior worse, that is rebound. If irritability is worse during the peak time of the stimulant during the day, that is a mood side effect (rare)

24 How to Handle Rebound If rebound occurs at 4 PM or symptoms do not controlled after 4 PM in spite of long acting: If room for improvement in daytime ADHD, increase AM dose of long-acting stimulant If perfect at school but sxs rebound at 4 PM, add short-acting stimulant in pm If rebound occurs later in night or is associated with severe predominately irritable mood add alpha agonist

25 Sculpting the Stimulant Dose Daytime Dose Concerta 18 mg Q AM Concerta Q AM Vyvanse 3-5 mg Q AM Vyvanse 6-7 mg Q AM Focalin XR 5 mg Q AM Focalin XR 1 mg Q AM Focalin XR 15-3 mg Q AM Afternoon Dose MPH 5 q 4 pm MPH 1-2* mg q 4 PM DEX/MSA 5 mg q 4 PM DEX/MSA 5 mg q 4 PM D-MPH 2.5 mg Q 4 PM D-MPH 5 mg Q 4 PM D-MPH 7.5-1* mg Q 4 PM *Caution regarding sleep and appetite

26 Adding Alpha Agonist Add for: Hyperarousal - either baseline or stimulant induced-irritable, crying, can t settle Partial response of ADHD symptoms when stimulant has been maximized Sleep issues Tics (as discussed)

27 Adding Alpha Agonist Sleep Problems Only Clonidine.1-.2 mg q hs Avoid doses above.2 mg Irritability PM only Guanfacine IR 1-2 mg Q 4 PM Can be added to pm stimulant dose All day irritability/partial response Intuniv 1-4 mg q AM Can give Intuniv q hs Clonidine ER helpful in severe hyperarousal, watch for sedation

28 Behavior Management The Psychology of ADHD There is no Why? Everything is short-term Parental ADHD/ADHD traits a problem ADHD children do not process rewards and punishments similar to typically developing children: Always go for immediate reward Cannot delay gratification Social rewards not salient - i.e. reinforcing

29 Behavioral Approaches Mon Tues Wen Thu Fri Sat Sun Don t hit sister Do things 1st time asked Homework Total

30 ADHD in Adults

31 Age-specific Prevalence of ADHD Remission 31 Biederman et al. Am J Psychiatry 2;157:816.

32 Age of Onset Issues DSM-5 now requires onset before age 12 Spirited debate among clinicians/researchers-does age of onset matter? Avoiding ADHD, when I wanna be Prevalence of adult ADHD when childhood onset is required is 4.4% (Kendler et al)

33 Impact of ADHD in Adolescence 6 ADHD Normal Percent subjects (%) Harpin V A Arch Dis Child 25;9:i2-i7.

34 ADHD-associated Behaviors Percent subjects (%) P<.1 P<.1 P<.1 P<.1 P<.1 P=NS P<.1 ADHD, n = 23, ages 12-2 years at follow-up Normal, n = 66 P=NS P<.1 P=NS 34 Harpin VA Arch Dis Child 25;9:i2-i7.

35 Diagnostic Interview of Adult ADHD Patient Chief complaint vs. latent comorbidity Screening Were you treated for ADHD as a child? Did you have grade or behavior problems in elementary/middle school? Do you remember having focus/attention problems as child? Parents/teachers always saying, Sit still, Get back to work, I have told you a thousand times! Did this happen more to you than your siblings? 35

36 36 Type: How to fake ADHD into Google, this is but one of many websites

37 Collateral Informants Documenting age of onset Medical records School records Parent report Intellectual ability Functional impairment, information from employer? 37

38 QUESTIONS?

39 Methylphenidate and Serious Cardiovascular Events in Adults Cohort study (212) of new users of methylphenidate [MPH] based on administrative data from a five-state Medicaid database and a 14-state commercial insurance database Recent 43,999 new MPH users, 175,955 nonusers (no MPH, amphetamine [AMP] or atomoxetine [ATX]) Too few AMP, ATX users to make comparison, but results most likely apply to AMP as well Examined rates of sudden death, arrhythmia, stroke, myocardial infarction, composite endpoint Study results: next slide 39 Schelleman et al. Am J Psychiatry 169:178, 212 (Shire-funded study).

40 Methylphenidate and Cardiovascular Events 2.17/1 patient years vs..98/1 in non users * * 4

41 ADHD, Medical Outcome and Cause of Death Olazagasti et al, JAACAP 52: , year follow up of 135/27 boys with ADHD (with and without Conduct Disorder) and 136/178 matched comparison boys Interviewed blind to original diagnosis, mean age 41.4 ± 3.2 years 41

42 ADHD and Medical Outcomes 6 Percent of sample * * * * * P <.5 ADHD Controls 42 Comorbidity of CD accounted for the relationship Olazagasti et al JAACP, Jan 213.

43 ADHD and Cause of Death * * All causes Medical Suicide Drugs/Accident * * P <.5 ADHD Controls 43 Comorbidity of CD accounted for the relationship Olazagasti et al JAACP, Jan 213.

44 Maximum Doses in Adults Methylphenidate Amphetamine Immediate release 6-8 mg/day 6 mg/day Concerta 18 mg Adderall 6 mg/day Vyvanse 1 mg/day Focalin XR 5 mg/day No need for Mega doses Use Texas PMP aware

45 Accommodations Many universities may require Evidence of childhood treatment Repeat of evaluation or evidence of comprehensive evaluation High functioning person who request diagnosis in adulthood ( I always could compensate ) Many accommodations used (extra time on tests) may not provide specific benefit to ADHD and may be unfair to other students Students need to be warned about need to report self in certain occupations

29 th Annual Learning Symposium

29 th Annual Learning Symposium Friday, January 5, 9 Breakout Session 9 th Annual Learning Symposium ADHD & Medication Steven Pliszka, M.D. Dr. Steven Pliszka is a Dielmann Distinguished Professor and Chair of the Department of Psychiatry

More information

28 th Annual Learning Symposium

28 th Annual Learning Symposium Friday, January 6, 8 Breakout Session 8 th Annual Learning Symposium ADHD & Medication Steven Pliszka, M.D. Presented by: Steven Pliszka, M.D. Dielmann Distinguished Professor and Chair Department of Psychiatry,

More information

Perspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry

Perspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Perspective Truth on ADHD & Medications Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Disclosures National Institute of Health ADHD and Aggression Study Co- Investigator

More information

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry

More information

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6 in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,

More information

ADHD Part II: Managing Comorbities

ADHD Part II: Managing Comorbities ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have

More information

The Use of ADHD Medication in the Pediatric Population

The Use of ADHD Medication in the Pediatric Population The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications

More information

Pharmacologic Management of ADHD

Pharmacologic Management of ADHD Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine

More information

Parents Guide to ADHD Medications. Copyright Child Mind Institute

Parents Guide to ADHD Medications. Copyright Child Mind Institute Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive

More information

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Update 5 Report July 2015 The purpose of reports is to make available information regarding the comparative

More information

ADHD Explanation 5: Medications used in ADHD

ADHD Explanation 5: Medications used in ADHD ADHD Explanation 5: Medications The aim of treatment is efficient functioning and achieving goals in life It is most important to find the dose of medications that works best As children grow they may

More information

AD/HD is a mental disorder, and it often lasts from

AD/HD is a mental disorder, and it often lasts from short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.

More information

Attention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD

Attention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD Attention Deficit Hyperactivity Disorder State of the Art Christopher Okiishi, MD What is ADHD? Three subtypes: Inattentive (under diagnosed, esp. in girls) Hyperactive Impulsive Combined Impairments must

More information

What are the most common signs of ADHD? And what are the most common medication interventions?

What are the most common signs of ADHD? And what are the most common medication interventions? What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina

More information

University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 5 February History of stimulant treatment

University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 5 February History of stimulant treatment Pharmacological Treatment of Attention Deficit Hyperactivity Disorder and its comorbidities Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department

More information

Chelsea Murphy MS, NCC. Kennedy Health Systems

Chelsea Murphy MS, NCC. Kennedy Health Systems Chelsea Murphy MS, NCC Kennedy Health Systems What is ADHD? o Neurobiological Disorder deficit in the neurotransmitters (message senders within the brain) o Dopamine & Norepinephrine are not released as

More information

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*

More information

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs.

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs. MEDICATIONS FOR ADHD Group Main Use Medication Brand/ Form Dose Schedule Dose Range Most Common Side Effects for Group Pros for Group Cautions for Group methylphenidate Methylin Focalin (dexmethylphenidate)

More information

ADHD Medications: Basics. David Benhayon MD, PhD

ADHD Medications: Basics. David Benhayon MD, PhD ADHD Medications: Basics David Benhayon MD, PhD Goals & Objectives Understand basic classes of stimulants and equivalents Be exposed to role of nonstimulant alternatives Discuss the role of therapy in

More information

Update on the Treatment of ADHD 2019

Update on the Treatment of ADHD 2019 Update on the Treatment of ADHD 2019 James H. Beard, Jr., M.D, FAAP Developmental-Behavioral Pediatrician Division of Developmental Pediatrics The Rights of ADHD The right diagnosis of ADHD and co morbidities

More information

Conroe ADHD Solutions

Conroe ADHD Solutions Diagnosis and Medical Management of ADD/ADHD How do we make the diagnosis of ADD/ADHD? We are very careful to be sure we have the diagnosis correct before considering treatment. In the past there were

More information

Trouble shooting medication adjustment and side effect management in children with ADHD

Trouble shooting medication adjustment and side effect management in children with ADHD Trouble shooting medication adjustment and side effect management in children with ADHD Drs. Joanna Holland and Sarah Manos 44 th Annual Dalhousie Spring Refresher April 5, 2018 Disclosure We have no disclosures

More information

Changing Behavior. Can t get up. Refuses to get up for school. I like school. Sad Poor sleep Angry Thoughts of self harm.

Changing Behavior. Can t get up. Refuses to get up for school. I like school. Sad Poor sleep Angry Thoughts of self harm. Changing Behavior I like school Can t get up. Refuses to get up for school. Mostly happy Larry Burd, PhD North Dakota Fetal Alcohol Syndrome Center 501 North Columbia Road Grand Forks ND, 58203 larry.burd@med.und.edu

More information

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,

More information

Attention Deficit Hyperactivity Disorder Overview and New Perspectives

Attention Deficit Hyperactivity Disorder Overview and New Perspectives 1st Annual Regional Psychiatry Conference Psychiatry for the Non-Psychiatrist Attention Deficit Hyperactivity Disorder Overview and New Perspectives Thomas B. Henry, MD Board Certified Child & Adolescent

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE: DYANAVEL XR (amphetamine) extended-release oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

DRUGS FOR ADHD: ADOLESCENTS TO ADULTS

DRUGS FOR ADHD: ADOLESCENTS TO ADULTS DRUGS FOR ADHD: ADOLESCENTS TO ADULTS DISCLOSURE Natasha Rodney-Cail, Pharmacist, Drug Evaluation Unit Has no conflicts of interest Dr. James Chandler, MD, FRCPC Has no conflicts of interest STEVEN Age

More information

Pharmacotherapy of ADHD with Non-Stimulants

Pharmacotherapy of ADHD with Non-Stimulants Pharmacotherapy of ADHD with Non-Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts

More information

Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition

Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Presented by Cat Dang, D.O Medical Director - Insightful Minds, Inc. Objectives Evaluation process Pharmacology

More information

ADHD: Management Update

ADHD: Management Update 4/5/17 Conflicts of Interest ADHD: Management Update I have no conflicts to disclose. Jennifer R. Walton, MD, MPH, FAAP April 7, 2017 ADHD: DSM-5 Definition Objectives To briefly review ADHD diagnostic

More information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information Adderall and Adderall-XR (amphetamine mixtures) Concerta (methylphenidate, controlled Dexedrine, Dexedrine Spansules (dextroamphetamine) Focalin (dexmethylphenidate) Metadate, Metadate-ER, and Metadate-CD

More information

Pharmacotherapy of ADHD with Non- Stimulants

Pharmacotherapy of ADHD with Non- Stimulants Pharmacotherapy of ADHD with Non- Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts

More information

PL CE LIVE February 2011 Forum

PL CE LIVE February 2011 Forum February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics

More information

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy Override(s) Prior Authorization ADHD Narcolepsy Approval Duration 1 year *Louisiana, Washington and Maryland Medicaid See State Specific Information Below Medications Atomoxetine: Strattera generic Clonidine

More information

Intelligent Prescribing. Optimizing Medication Treatments in ADHD Dr Dave Coghill

Intelligent Prescribing. Optimizing Medication Treatments in ADHD Dr Dave Coghill Intelligent Prescribing Optimizing Medication Treatments in ADHD Dr Dave Coghill Source Consultant Advisory Board Stock Equity >$10,000 Speaker Research Lilly X X X Janssen/ McNeil X X X UCB X X Shire

More information

Presented by the National Resource Center on ADHD

Presented by the National Resource Center on ADHD Presented by the National Resource Center on ADHD Timothy E. Wilens, M.D. Massachusetts General Hospital Harvard Medical School Save 25% if you join/rejoin CHADD Use Promo Code: JANA14 If you are currently

More information

Practical Psychopharmacology for More Complex Mental Health Presentations

Practical Psychopharmacology for More Complex Mental Health Presentations MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More

More information

Psychopharmacology of ADHD. Copyright 2006 Neuroscience Education Institute. All rights reserved.

Psychopharmacology of ADHD. Copyright 2006 Neuroscience Education Institute. All rights reserved. Psychopharmacology of ADHD Persistence (Predicted Value) Persistence of ADHD Into Adulthood 90 80 70 60 50 40 30 20 10 0 NA 10 15 20 25 30 Age at Follow-Up Syndromatic Persistence Symptomatic Persistence

More information

Child/Adolescent Attention-Deficit/Hyperactivity Disorder

Child/Adolescent Attention-Deficit/Hyperactivity Disorder Child/Adolescent Attention-Deficit/Hyperactivity Disorder NATIONAL GUIDELINE SUMMARY This evidence-based guideline summary is based on the 2009 National Child/Adolescent Attention-Defict/ Hyperactivity

More information

Medications in Autism: What We Know and Don't Know

Medications in Autism: What We Know and Don't Know Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental

More information

To Give or not to Give Medication: That is the Question

To Give or not to Give Medication: That is the Question To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental

More information

Practical care of the Child with ADHD Kristina Hingre MD

Practical care of the Child with ADHD Kristina Hingre MD Practical care of the Child with ADHD Kristina Hingre MD Objectives Know the DSM 5 Criteria for diagnosis of ADHD Identify 4 Comorbidities of ADHD Be familiar with the common ADHD medications and Side

More information

Recognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives

Recognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives Southern California Permanente Medical Group Pediatric Symposium Hyatt, Long Beach CA. 11/1/13 Recognition and Treatment of ADHD in Primary Care Settings Martin T. Stein, M.D. Professor of Pediatrics Division

More information

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Child & Adolescent Psychiatry (a brief overview)

Child & Adolescent Psychiatry (a brief overview) Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina

More information

Attention Deficit Hyperactivity Disorder How to manage these disorganized and inattentive children.

Attention Deficit Hyperactivity Disorder How to manage these disorganized and inattentive children. Attention Deficit Hyperactivity Disorder How to manage these disorganized and inattentive children. One of the leading authorities on Attention Deficit Hyperactivity Disorder, Russell Barkley, PhD., defines

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

23/06/2015. Absolutely none!!

23/06/2015. Absolutely none!! Absolutely none!! Child and adolescent Mental Health can we help? Dr Tina Nicholson CCFP Family Practitioner and Medical Lead, Cochrane Clinical Lecturer Dept Family Med. U of C. Member of CanReach Faculty

More information

Behavioural Disorders

Behavioural Disorders Behavioural Disorders BEH Hyperkinetic disorder / attention deficit hyperactivity disorder (ADHD) Behavioural disorders is an umbrella term that includes more specific disorders, such as hyperkinetic disorder

More information

Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D.

Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. PREVALENCE & STATISTICS 6-8% of all children have ADHD (CDC Statistical Data) Age of onset: 7 years old (Prior DSM-IV) 12 years old (Current

More information

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to

More information

Child/Adolescent Attention-Deficit/Hyperactivity Disorder

Child/Adolescent Attention-Deficit/Hyperactivity Disorder Child/Adolescent Attention-Deficit/Hyperactivity Disorder NATIONAL GUIDELINE SUMMARY This evidence-based guideline summary is based on the 202 National Child/Adolescent Attention-Defict/ Hyperactivity

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

ADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27

ADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27 ADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27 Considering ADHD diagnosis? Problem from inattention/hyperactivity Consider comorbidity or other diagnosis: Oppositional Defiant Disorder Conduct

More information

Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Report Update 3 September 2009 Update 2: November 2007 Update 1: May 2006 Original Report: September 2005 The

More information

Case Vignettes ANSWER KEY

Case Vignettes ANSWER KEY Case Vignettes ANSWER KEY CASE 1 Cesar, an 8 year old, 38 kg Hispanic boy, presents to your office, transferring care from another PCP across town. He presents with complaints of significant hyperactivity,

More information

Clonidine extended-release tablets for the treatment of ADHD

Clonidine extended-release tablets for the treatment of ADHD Clonidine extended-release tablets for the treatment of ADHD Joan Daughton*, Lindsey Corr, Howard Liu & Madeline West Practice points Stimulant medications remain the first-line treatment for ADHD. Based

More information

IRONSHORE TO PRESENT THREE POSTERS AT THE 2019 ANNUAL AMERICAN PROFESSIONAL SOCIETY OF ADHD AND RELATED DISORDERS (APSARD) MEETING

IRONSHORE TO PRESENT THREE POSTERS AT THE 2019 ANNUAL AMERICAN PROFESSIONAL SOCIETY OF ADHD AND RELATED DISORDERS (APSARD) MEETING FOR IMMEDIATE RELEASE IRONSHORE TO PRESENT THREE POSTERS AT THE 2019 ANNUAL AMERICAN PROFESSIONAL SOCIETY OF ADHD AND RELATED DISORDERS (APSARD) MEETING George Town, Cayman Islands January 10, 2019 Ironshore

More information

Emotional lability in adults with ADHD: a core feature

Emotional lability in adults with ADHD: a core feature Emotional lability in adults with ADHD: a core feature Philip Asherson MRCPsych, PhD Professor of Clinical and Molecular Psychiatry & Honorary Consultant Psychiatrist, MRC Social Genetic Developmental

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

ADHD:Updates and Practical Suggestions

ADHD:Updates and Practical Suggestions :Updates and Practical Suggestions Elizabeth Reeve MD HealthPartners Medical Group Disclosure I have no financial disclosures I may be talking about non FDA approved indications for medications Elizabeth.A.Reeve@HealthPartners.com

More information

ADHD and social skills M. T. LAX-PERICALL CONSULTANT IN CHILD AND ADOLESCENT PSYCHIATRY PRIORY HOSPITAL ROEHAMPTON

ADHD and social skills M. T. LAX-PERICALL CONSULTANT IN CHILD AND ADOLESCENT PSYCHIATRY PRIORY HOSPITAL ROEHAMPTON ADHD and social skills M. T. LAX-PERICALL CONSULTANT IN CHILD AND ADOLESCENT PSYCHIATRY PRIORY HOSPITAL ROEHAMPTON ADHD (DSM-5) persistent pattern of inattention and/or hyperactivity-impulsivity that interferes

More information

Facts about ADHD drugs as treatment

Facts about ADHD drugs as treatment Facts about ADHD drugs as treatment Common ADHD drugs as treatment Medication Stimulants Methylphenidate Dexmethylphenidate Amphetamine Non-Stimulants Straterra Guanfacine ER (Intuniv) Clonidine (Kapvay)

More information

Attention Deficit Hyperactivity Disorder or ADHD

Attention Deficit Hyperactivity Disorder or ADHD Diagnosis/Disease/Illness Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. Name of Child: Date: Attention Deficit Hyperactivity Disorder or ADHD What it is: Children

More information

MANAGEMENT OF ADHD IN ADULTS

MANAGEMENT OF ADHD IN ADULTS MANAGEMENT OF ADHD IN ADULTS RICHARD MOLDAWSKY, M.D. I Can t Focus on Anything Except Getting My Adderall 1 ASSUMPTIONS FOR TODAY Most of us don t work 2 W s without seeing a person with ADHD You are familiar

More information

Depression, Anxiety, and the Adolescent Athlete: Introduction to Identification and Treatment

Depression, Anxiety, and the Adolescent Athlete: Introduction to Identification and Treatment Depression, Anxiety, and the Adolescent Athlete: Introduction to Identification and Treatment Jamie E. Pardini, PhD Sports Medicine and Concussion Specialists Banner University Medical Center-Phoenix University

More information

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,

More information

Biology Change Pressure Identity and Self-Image

Biology Change Pressure Identity and Self-Image Victoria L Foster Biology Change Pressure Identity and Self-Image Sadness Sadness is something we all experience. Sadness is usually tied to one event or reason. Sadness is what happens when normal

More information

ADHD: A Focus On Drug Therapy

ADHD: A Focus On Drug Therapy ADHD: A Focus On Drug Therapy MARY WORTHINGTON, PHARM.D., BCPS MCWHORTER SCHOOL OF PHARMACY BIRMINGHAM, ALABAMA SEPTEMBER 13, 2013 Outpatient Prescription Drug Utilization in US Children, 2002-2010 90

More information

Psychiatric medication treatment in children and adolescents:

Psychiatric medication treatment in children and adolescents: Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018.

Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018. Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018 Disclosures I have no conflicts of interest to disclose 1 Objectives

More information

Driving to Distraction

Driving to Distraction Driving to Distraction New Research on the Impact of ADHD and ADHD Medications on Driving performance Daniel J. Cox, Ph.D., A.B.P.P Professor, Departments of Psychiatric and Internal Medicine Director,

More information

WI Alliance of Child Psychiatry and Pediatrics CASE STUDY. Mood Disorders. James A. Meyer MD Adolescent Medicine Marshfield Clinic

WI Alliance of Child Psychiatry and Pediatrics CASE STUDY. Mood Disorders. James A. Meyer MD Adolescent Medicine Marshfield Clinic WI Alliance of Child Psychiatry and Pediatrics CASE STUDY Mood Disorders 12-09-2014 James A. Meyer MD Adolescent Medicine Marshfield Clinic Disclosure Statement I, James Meyer, M.D., do not have any relevant

More information

Pediatrics Grand Rounds 5 March University of Texas Health Science Center at San Antonio I-1

Pediatrics Grand Rounds 5 March University of Texas Health Science Center at San Antonio I-1 Diagnosis and Treatment of Depression in Children and Adolescents Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department of Psychiatry The Disclosures

More information

Management Options for Attention Deficit Hyperactivity Disorder. Public Meeting June 1, 2012

Management Options for Attention Deficit Hyperactivity Disorder. Public Meeting June 1, 2012 Management Options for Attention Deficit Hyperactivity Disorder Public Meeting June 1, 2012 New England CEPAC Goal: To improve the application of evidence to guide practice and policy in New England Method:

More information

written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder

written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder www.patientedu.org Every child gets restless and fidgety from time to time; in particular, boys are often bursting with energy

More information

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment. Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor

More information

Attention Deficit Hyperactive Disorder (ADHD)

Attention Deficit Hyperactive Disorder (ADHD) E-Resource September, 2015 Attention Deficit Hyperactive Disorder (ADHD) Attention Deficit Hyperactivity Disorder (ADHD) is the most common childhood behavioral health concern noticed in primary care.

More information

ADHD ATTENTION-DEFICIT HYPERACTIVITY DISORDER

ADHD ATTENTION-DEFICIT HYPERACTIVITY DISORDER ADHD ATTENTION-DEFICIT HYPERACTIVITY DISORDER These cards will help you and your child set goals for treatment. It provides an overview of treatment options available to you. The booklet lists more information

More information

We ll Be Discussing. Pregnancy 4/24/2013

We ll Be Discussing. Pregnancy 4/24/2013 Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track

More information

11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE

11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary

More information

DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES

DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES Scott R. Smith, MD, MPH Developmental-Behavioral Pediatrician University of Rochester Medical Center Common Complaints about Children with Problems Your

More information

Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand

Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand The 25th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2014 Kota Kinabalu, Sabah, Malaysia 9th - 12th October, 2014 Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

A Closer Look: NH Primary Care Clinician Perspective on Caring for Pediatric Patients with ADHD

A Closer Look: NH Primary Care Clinician Perspective on Caring for Pediatric Patients with ADHD A Closer Look: NH Primary Care Clinician Perspective on Caring for Pediatric Patients with ADHD W. Burleson Daviss, MD Dept. of Psychiatry / DHMC Molly O Neil University of New Hampshire Objectives 1)

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.PMA_10.11.7 Effective Date: 07.16 Last Review Date: 04.18 Line of Business: Cenpatico Medicaid Arizona Revision Log See Important Reminder at the end of this policy

More information

Name:, Sex:, Age: Ethnicity, Race. Date of Birth:, address: Address:, City: State:, County,, Zip: Telephone numbers: Home: ( ),Work: ( )

Name:, Sex:, Age: Ethnicity, Race. Date of Birth:,  address: Address:, City: State:, County,, Zip: Telephone numbers: Home: ( ),Work: ( ) Adult Patient Information Name:, Sex:, Age: Ethnicity, Race Date of Birth:, Email address: Address:, City: State:, County,, Zip: Telephone numbers: Home: ( ),Work: ( ) Cell: ( ) Referral by: Person to

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

AD/HD Across the Lifespan. Michael F. Finkel MD, FAAN. Department of Neurology. Medical and Surgical Specialists Naples, Florida.

AD/HD Across the Lifespan. Michael F. Finkel MD, FAAN. Department of Neurology. Medical and Surgical Specialists Naples, Florida. AD/HD Across the Lifespan Michael F. Finkel MD, FAAN. Department of Neurology. Medical and Surgical Specialists Naples, Florida. Worldwide Prevalence of ADHD Is 3% to 7% Studies of ADHD prevalence United

More information

Warning Signs of Mental Illness in Children/Adolescents. Beth Confer, MA, LPC Director, Community Relations Clarity Child Guidance Center

Warning Signs of Mental Illness in Children/Adolescents. Beth Confer, MA, LPC Director, Community Relations Clarity Child Guidance Center Warning Signs of Mental Illness in Children/Adolescents Beth Confer, MA, LPC Director, Community Relations Clarity Child Guidance Center Identify At least 5 warning signs of mental illness in children

More information

Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD

Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD Dr. Don Duncan Clinical Director BC Interior ADHD Clinic Kelowna, BC Mental Health Summit Vancouver, BC December

More information

Attention Deficit Hyperactivity Disorder: Module 3

Attention Deficit Hyperactivity Disorder: Module 3 Attention Deficit Hyperactivity Disorder: Module 3 The information in this training module was taken from an online article by the National Institute of Mental Health. (http://www.nimh.nih. gov/health/publications/adhd/complete-publication.shtml)

More information

ADHD: Overcome misconceptions and treat with confidence

ADHD: Overcome misconceptions and treat with confidence ADHD: Overcome misconceptions and treat with confidence Dr. Joan Flood Family Physician, The Shoniker Clinic, Scarborough Board Member, The Canadian ADHD Resource Alliance (CADDRA) Chair, Advocacy Committee,

More information

BIPOLAR DISORDER AND ADHD IN CHILDREN

BIPOLAR DISORDER AND ADHD IN CHILDREN BIPOLAR DISORDER AND ADHD IN CHILDREN BIPOLAR I DISORDER IS BEING DIAGNOSED WITH INCREASING FREQUENCY (INTENSITY) IN PRE-PUBERTAL CHIDREN WITH THE CAVEAT (WARNING / STIPULATION) THAT CLASSIC MANIC EPISODES

More information

ADHD Overview and Update

ADHD Overview and Update ADHD Overview and Update David Camenisch, MD Child and Adolescent Psychiatrist Seattle Children s Hospital Origin of ADHD Evolutionary/societal advantages? Past could risk-taking, reactivity, novelty seeking

More information

Beyond the Practice Parameters

Beyond the Practice Parameters Volume 17 l Number 3 l Fall 2010 Attention Deficit Hyperactivity Disorder: Beyond the Practice Parameters By Shelly Flynn, RN, MA, ARNP Division of Pediatric Neurology, Behavior and Development University

More information

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

5 COMMON QUESTIONS WHEN TREATING DEPRESSION 5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective

More information